Overview
The H.A. and Mary K. Chapman Charitable Foundations Genomic Sequencing Core’s mission is to help facilitate cutting-edge genomics research at the Salk Institute by providing rapid high-throughput sequencing services, consultation and expert assistance in strategic planning and method development.
The core houses state-of-the-art equipment in sequencing and genomics, including high-throughput sequencing systems such as Illumina NovaSeq 6000, NextSeq 2000, MiniSeq, and PacBio Sequel IIe system (long-read sequencing), as well as 10x Genomics Chromium Controller single-cell solution, NanoString nCounter MAX Analyzer and GeoMx Digital Spatial Profiler instrument, along with QuantStudio Real-Time PCR instruments.
Full list of equipment including self-service instruments here »
For submitting manuscripts that have made use of services or resources from this core, PLEASE ACKNOWLEDGE SUPPORT by inclusion of the following information:
“This work was supported by the NGS Core Facility of the Salk Institute with funding from NIH-NCI CCSG: P30 CA01495, NIH-NlA San Diego Nathan Shock Center P30 AG068635, the Chapman Foundation and the Helmsley Charitable Trust.” Please acknowledge core staff where appropriate and consider authorship inclusion when scientific contributions merit.
Please link each publication stemming from work performed in the core to your MyNCBI account. This will ensure that the contributions from NIH are appropriately acknowledged in renewal and continuation applications. This NIH requirement must be satisfied as part of our efforts to provide consistent access to stabling funded core resources. Information on how to link publications can be found here»
10010 N Torrey Pines Rd
La Jolla, CA 92037
Telephone: (858) 453-4100
Elsa Molina, PhD
Director
emolina@salk.edu
Location: South East Building, First Floor (Ground Floor)
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
